2026 MPN Patient Unmet Needs Assessment 

| Resume a previously saved form
Resume Later

In order to be able to resume this form later, please enter your email and choose a password.

Password must contain the following:
  • 12 Characters
  • 1 Uppercase letter
  • 1 Lowercase letter
  • 1 Number
  • 1 Special character

The assessment will take approximately 25 minutes to complete.

About this Assessment


The goal of this assessment is to better understand the current perspectives and experiences of myeloproliferative neoplasm (MPN) patients and share key insights with the broader MPN community.


Through this assessment, we aim to:

  • learn what services, resources, and information are known and how they’re perceived.

  • understand usage, accessibility, and satisfaction with existing offerings.
  • uncover gaps in services, resources, and information.
  • gauge the level of need and interest in addressing those gaps.

If you completed the 2024 assessment, your continued participation in 2026 is especially valuable. Hearing from the same individuals over time helps us understand what has changed, what has improved, and what challenges remain. This creates a clearer picture of trends, unmet needs, and the real impact of new treatments, care models, and patient support resources. Your ongoing involvement directly strengthens the quality and usefulness of this research.


Results will be shared with participants by Summer 2026. All responses are confidential. Names and email addresses are collected only to connect you with relevant opportunities.


By completing this assessment, you will be automatically subscribed to MPN Research Foundation’s mailing list to receive updates on programs, research, and more. You may unsubscribe at any time.


Your voice is vital to identifying and addressing unmet needs in the MPN community.


Questions? Email patientengagement@mpnrf.org 






Your input is important to us

This assessment is designed specifically for individuals living with an MPN, as it focuses on capturing patient-reported experiences.
If you are not a patient but would like to share observations, concerns, or unmet needs, we invite you to contact our Patient Engagement team at patientengagement@mpnrf.org. 

Demographics and patient journey 







































I have the information and education I need about: 
Strongly Disagree Disagree Neither Disagree nor Agree Agree Strongly Agree
Please select the option that best reflects your experience: 
Strongly Disagree Disagree Neither Disagree nor Agree Agree Strongly Agree
Please select the option that best reflects your experience: 
Strongly Disagree Disagree Neither Disagree nor Agree Agree Strongly Agree





An MPN Specialist is a physician who specializes in and sees patients with primarily MPNs and other closely aligned blood cancers.





A bone marrow biopsy is a procedure in which a small core of bone and marrow tissue is removed, usually from the back of the hip bone (pelvis), to examine cell production and bone marrow structure.

It’s often performed together with a bone marrow aspiration, which draws out the liquid portion of the marrow to study individual blood cells and genetic changes.

Allele burden refers to the proportion of DNA carrying a specific gene mutation (such as JAK2, CALR, or MPL) compared with normal (non-mutated) DNA in a sample.


For example, if you have the JAK2 V617F mutation and your allele burden is 40%, that means 40% of the JAK2 alleles detected in your blood sample carry the mutation. This does not necessarily mean 40% of your blood cells are mutated, since each cell has two copies of the gene and other genetic factors can influence the percentage.


Healthcare providers can share this number with patients if the test has been run. 


Next generation sequencing or NGS testing refers to tests done from the blood or the bone marrow (biopsy) that can look for many different genetic mutations at once.



Strongly Disagree Disagree Neither Disagree nor Agree Agree Strongly Agree

MPN therapies


Quick Facts! 

There are four FDA-approved JAK inhibitors for the treatment of myelofibrosis: ruxolitinib (Jakafi), fedratinib (Inrebic), pacritinib (VONJO), and momelotinib (OJJAARA). 

There are two types of interferons used for the treatment of MPNs: peginterferon alfa-2a (Pegasys) and ropeginterferon alfa-2b (BESREMi).

I understand and have the information I need surrounding:
Strongly Disagree Disagree Neither Disagree or Agree Agree Strongly Agree
Strongly Disagree Disagree Neither Disagree or Agree Agree Strongly Agree
Strongly Disagree Disagree Neither Disagree or Agree Agree Strongly Agree

Strongly Disagree Disagree Neither Disagree or Agree Agree Strongly Agree





Strongly Disagree Disagree Neither Disagree or Agree Agree Strongly Agree

MPN clinical trials 

Quick Facts!


Did you know there are over 130 trials listed currently on the National Institutes of Health (NIH) site (https://www.clinicaltrials.gov/) for MPNs? 

MPN Research Foundation provides tools and resources to support patients in identifying and navigating clinical trial options: https://mpnresearchfoundation.org/mpn-clinical-trials/
Strongly Disagree Disagree Neither Disagree or Agree Agree Strongly Agree








The following questions ask about factors that may influence your willingness to participate in a clinical trial.


For each item below, please indicate how much of a priority it is for you personally when considering whether to join a clinical trial.


After this question, you will be asked a follow-up question, you will be asked to  select your top priority. 

Not a priority Low priority Moderate priority High priority



MPN symptoms and conditions 

Quick Facts! 


MPN-10 Assessment Tool:


The MPN-10 is a patient-reported outcome (PRO) questionnaire designed to help patients and providers track how MPN-related symptoms affect daily life.

It includes 10 key symptoms commonly reported by MPN patients:

  1. Fatigue

  2. Early satiety (feeling full quickly when eating)

  3. Abdominal discomfort

  4. Inactivity

  5. Concentration problems (brain fog)

  6. Night sweats

  7. Itching (pruritus)

  8. Bone pain

  9. Fever

  10. Unintentional weight loss

Each symptom is rated by the patient on a scale of 0 to 10, with higher scores indicating more severe symptoms. The total score helps providers assess overall symptom burden and monitor changes over time or in response to treatment.










Strongly Disagree Disagree Neither Disagree or Agree Agree Strongly Agree




Access to information and resources







A nurse navigator is a specially trained nurse whose role is to guide patients and families through the complexities of the healthcare system, particularly after a new or serious diagnosis like cancer, a chronic illness, or a rare disease.




Strongly Disagree Disagree Neither Disagree or Agree Agree Strongly Agree






Emotional health and quality of life

Strongly Disagree Disagree Neither Disagree or Agree Agree Strongly Agree






Attention: Please be sure to hit submit below before exiting!


If the form asks you to go back and check an answer you may have missed, be sure to navigate back to page 9 to submit the form.